Section Editors

  • Michael Aschner, Vanderbilt University
  • Phil Biggin, University of Oxford
  • Lucio Guido Costa, University of Washington
  • David H Farb, Boston University School of Medicine
  • Giorgio Palu, University of Padova

Executive Editor

  • Christopher Morrey, BioMed Central

Articles

There has been an error retrieving the data. Please try again.

Latest review

Wikimedia Commons by DBCLS

Review Highly Accessed

Role of astrocytes in manganese mediated neurotoxicity

Marta Sidoryk-Wegrzynowicz and Michael Aschner

BMC Pharmacology and Toxicology 2013, 14:23 (18 April 2013)

RSS

Comments

View more comments

Scope

BMC Pharmacology and Toxicology is an open access, peer-reviewed journal that considers articles on all aspects of chemically defined therapeutic and toxic agents. The journal welcomes submissions from all fields of experimental and clinical pharmacology including clinical trials.

It is journal policy to publish work deemed by peer reviewers to be a coherent and sound addition to scientific knowledge and to put less emphasis on interest levels, provided that the research constitutes a useful contribution to the field.

Section Editor's profile

David H Farb

David H Farb is Professor and Chair of the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine. He is Principal Investigator and Director of the Laboratory of Molecular Neurobiology and Director of the university-wide NIGMS training program in Biomolecular Pharmacology. A renowned neuropharmacologist, his research integrates existing electrophysiological, behavioral, pharmacological, and molecular genetic technologies in a novel systems-level platform to establish a molecular dissection of spatial memory. Dr Farb is Section Editor for 'Basic pharmacology' and you can read more about the key issues in this field and his aspirations for the journal in his recent interview here.

"Pharmacology is a powerful interdisciplinary science providing an essential link between hypotheses developed from molecular, systems, and clinical models with the ultimate goal of improving human health. Our journal publishes timely research describing advances in a broad range of disciplines that combine novel approaches within a framework of rigorous scientific research."

Join the Editorial Board!

Are you interested in becoming an Editorial Board member for BMC Pharmacology and Toxicology and helping to maintain the editorial standards and ethos of this growing journal? To volunteer as an Associate Editor, please simply contact us at bmcpharmacoltoxicol@biomedcentral.com, enclosing a summary of your research interests and relevant expertise. We look forward to hearing from you.

BMC Pharmacology

BMC Pharmacology and Toxicology assimilated the Editorial boards and history of BMC Pharmacology and BMC Clinical Pharmacology on fusion of the journals in 2012. The full archive of BMC Pharmacology is available from its own archive website, and the objectives and aspirations of the merged journal are explained in the editorial that accompanied the fusion. The full archive of BMC Clinical Pharmacology is available here.

Submit a manuscript Sign up for article alerts Contact us

Email updates

Receive periodic news and updates relating to BioMed Central straight to your inbox.

Indexed by

  • CAS
  • Embase
  • Journal Citation Reports/Science Edition
  • MEDLINE
  • PubMed
  • Science Citation Index Expanded
  • Scopus

View all

ISSN: 2050-6511